Colgate-Palmolive Company (NYSE:CL), a global leader in consumer products with a market capitalization of $73.26 billion, has been navigating a complex market landscape characterized by strong brand ...

KR Choksey recommended reduce rating on Colgate Palmolive India with a target price of Rs 2721 in its research report dated ...

Geneos Wealth Management Inc. lessened its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 3.3% during the ...

Prabhudas Lilladher recommended hold rating on Colgate Palmolive with a target price of Rs 2801 in its research report dated January 28, 2025.

Morgan Stanley analyst Dara Mohsenian maintained a Buy rating on Colgate-Palmolive (CL – Research Report) today and set a price target of ...

This complaint was first surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and ...

BofA Securities adjusted its price target for Colgate-Palmolive (NYSE:CL) India (CLGT:IN) to INR2,930 from the previous INR2,955 while maintaining a Buy rating on the stock. The revision follows the ...

FMCG major Colgate-Palmolive India Ltd on Tuesday reported a 2.22 per cent decline in its net profit to Rs 322.78 crore for ...

Companies in the Consumer Goods sector have received a lot of coverage today as analysts weigh in on Colgate-Palmolive (CL – Research Report) ...

Colgate Palmolive (India) reported a third-quarter profit that came in below market estimates on Tuesday, hurt by dwindling demand from urban consumers and higher expenses.

Colgate-Palmolive India's Q3 profit declined 2.22% to Rs 322.78 crore due to soft urban demand and high base from last year.

Ltd has reported a steady yet somewhat subdued financial performance for the third quarter and nine months ending 31 December 2024. In a world where Pepsodent, Sensodyne, and a slew of herbal ...